Fructose and tagatose protect against oxidative cell injury by iron chelation.
To further investigate the mechanism by which fructose affords protection against oxidative cell injury, cultured rat hepatocytes were exposed to cocaine (300 microM) or nitrofurantoin (400 microM). Both drugs elicited massively increased lactate dehydrogenase release. The addition of the ketohexoses D-fructose (metabolized via glycolysis) or D-tagatose (poor glycolytic substrate) significantly attenuated cocaine- and nitrofurantoin-induced cell injury, although both fructose and tagatose caused a rapid depletion of ATP and compromised the cellular energy charge. Furthermore, fructose, tagatose, and sorbose all inhibited in a concentration-dependent manner (0-16 mM) luminolenhanced chemiluminescence (CL) in cell homogenates, indicating that these compounds inhibit the iron-dependent reactive oxygen species (ROS)-mediated peroxidation of luminol. Indeed, both Fe2+ and Fe3+ further increased cocaine-stimulated CL, which was markedly quenched following addition of the ketohexoses. The iron-independent formation of superoxide anion radicals (acetylated cytochrome c reduction) induced by the prooxidant drugs remained unaffected by fructose or tagatose. The iron-chelator deferoxamine similarly protected against prooxidant-induced cell injury. In contrast, the nonchelating aldohexoses D-glucose and D-galactose did not inhibit luminol CL nor did they protect against oxidative cell injury. These data indicate that ketohexoses can effectively protect against prooxidant-induced cell injury, independent of their glycolytic metabolism, by suppressing the iron-catalyzed formation of ROS.
Valeri
F
F
Institute of Toxicology, ETH, Schwerzenbach, Switzerland.
Boess
F
F
Wolf
A
A
Göldlin
C
C
Boelsterli
U A
UA
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005632:Fructose / Q000494:pharmacology*; D006019:Glycolysis / Q000187:drug effects; D006601:Hexoses / Q000494:pharmacology*; D017665:Hydroxyl Radical; D007502:Iron Chelating Agents / Q000494:pharmacology*; D019344:Lactic Acid / Q000096:biosynthesis; D008163:Luminescent Measurements; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species
D004791:Enzyme Inhibitors; D006601:Hexoses; D007502:Iron Chelating Agents; D017382:Reactive Oxygen Species; D005632:Fructose; D017665:Hydroxyl Radical; D019344:Lactic Acid; D000255:Adenosine Triphosphate; C030192:tagatose